Spots Global Cancer Trial Database for sickle cell disease
Every month we try and update this database with for sickle cell disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Distracting Through Procedural Pain and Distress | NCT04892160 | Chronic Illness Hematologic Mal... Bone Marrow Tra... Oncology Sickle Cell Dis... | Guided Imagery Virtual Reality | 8 Years - 25 Years | Medical College of Wisconsin | |
| Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN) | NCT02895841 | Pain | SMART app weara... | 8 Years - 80 Years | Duke University | |
| Massive Iron Deposit Assessment | NCT01572922 | Iron Overload Excessive Body ... | R2*-UTE R2*-GRE Liver biopsy | - | St. Jude Children's Research Hospital | |
| Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions | NCT03938324 | Sickle Cell Dis... Chronic Kidney ... Systemic Lupus ... Childhood Cance... Inflammatory Bo... Stem Cell Trans... Organ Transplan... Diabetes Mellit... Cystic Fibrosis | PiCASO Interven... Sham Comparator... | 16 Years - 22 Years | Duke University | |
| Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | NCT05635266 | Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo | Specimen sample | 18 Years - 85 Years | Sanguine Biosciences | |
| Comorbidities and Risk Score in COVID-19 Patients | NCT04670094 | Covid19 | 18 Years - | University of Milano Bicocca | ||
| Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation | NCT01316549 | Hematologic Mal... Nonmalignant Di... Immunodeficienc... Hemoglobinopath... Genetic Inborn ... Fanconi Anemia Thalassemia Sickle Cell Dis... | Fludarabine | - 17 Years | University of California, San Francisco | |
| Medication Adherence and Non-adherence in Adults With Rare Disease | NCT04541875 | Cystic Fibrosis Hemophilia A Hemophilia B Idiopathic Pulm... Myasthenia Grav... Sickle Cell Dis... | MAR-Scale | 18 Years - | Xperiome | |
| Massive Iron Deposit Assessment | NCT01572922 | Iron Overload Excessive Body ... | R2*-UTE R2*-GRE Liver biopsy | - | St. Jude Children's Research Hospital | |
| SELF-BREATHE RCT for Chronic Breathlessness | NCT04574050 | Cancer COPD Asthma Bronchiectasis ... Interstitial Lu... Cystic Fibrosis Chronic Heart F... Sickle Cell Dis... Renal Failure Liver Failure Post COVID-19 Dyspnea | SELF-BREATHE | 18 Years - | King's College Hospital NHS Trust | |
| Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) | NCT03904134 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Non-hodgkin Lym... Hodgkin Lymphom... Acquired Aplast... Sickle Cell Dis... | Donor Search Pr... | - | Center for International Blood and Marrow Transplant Research | |
| Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients | NCT05255445 | Sickle Cell Dis... Thalassemia Pediatric Cance... | Red Blood Cell ... | - | Westat | |
| Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | NCT03609840 | Hematologic Mal... Nonmalignant Di... Immune Deficien... Hemoglobinopath... Genetic Inborn ... Fanconi Anemia Thalassemia Sickle Cell Dis... | Thiotepa | - 17 Years | University of California, San Francisco | |
| ORCHARD- Optimising Home Assessment of Rural Patients | NCT05732922 | Organ Transplan... Cancer Inborn Errors o... Immunosuppressi... COPD Asthma Sickle Cell Dis... | A sphygmanomete... | 18 Years - 100 Years | University of Aberdeen | |
| Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting | NCT01673243 | Smoking Cancer Sickle Cell Dis... | Questionnaire | - | St. Jude Children's Research Hospital | |
| Validating Pain Scales in Children and Young Adults | NCT01639950 | Sickle Cell Dis... Solid Tumor Leukemia Neurofibromatos... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | NCT03609840 | Hematologic Mal... Nonmalignant Di... Immune Deficien... Hemoglobinopath... Genetic Inborn ... Fanconi Anemia Thalassemia Sickle Cell Dis... | Thiotepa | - 17 Years | University of California, San Francisco | |
| Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) | NCT00236041 | Cancer Breakthrough Pa... | ACTIQ® | 3 Years - 15 Years | Teva Branded Pharmaceutical Products R&D, Inc. | |
| FOCUS for Pediatric Sickle Cell Disease and Cancer | NCT04075877 | Pediatric Cance... Sickle Cell Dis... Quality of Life Depressive Symp... Coping Skills | FOCUS | 12 Years - 18 Years | Georgia State University | |
| Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation | NCT01316549 | Hematologic Mal... Nonmalignant Di... Immunodeficienc... Hemoglobinopath... Genetic Inborn ... Fanconi Anemia Thalassemia Sickle Cell Dis... | Fludarabine | - 17 Years | University of California, San Francisco | |
| Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting | NCT01673243 | Smoking Cancer Sickle Cell Dis... | Questionnaire | - | St. Jude Children's Research Hospital | |
| Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations | NCT01911871 | Thalassemia Sickle Cell Dis... Myelodysplasia | Blood sample | 6 Years - | Assistance Publique - Hôpitaux de Paris | |
| Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | NCT03609827 | Hematologic Mal... Nonmalignant Di... Immunodeficienc... Hemoglobinopath... Genetic Inborn ... Fanconi's Anemi... Thalassemia Sickle Cell Dis... | Melphalan | - 17 Years | University of California, San Francisco | |
| AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion | NCT04099966 | Acute Leukemia Severe Aplastic... Non-hodgkin Lym... Hodgkin Lymphom... Kostmann Diamond Blackfa... Amegakaryocytic... Sickle Cell Dis... Beta-Thalassemi... | alpha beta depl... | 1 Day - 30 Years | New York Medical College | |
| Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting | NCT01673243 | Smoking Cancer Sickle Cell Dis... | Questionnaire | - | St. Jude Children's Research Hospital | |
| Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants | NCT01881334 | Hematologic Mal... Inborn Errors o... Immune Deficien... | CliniMACS CD34 ... | - 65 Years | Duke University | |
| Kid Cards: Teaching Kids About Medicines | NCT00127543 | Hemophilia Sickle Cell Dis... Neoplasms Blood Coagulati... | Medication Educ... | 7 Years - 11 Years | Children's Mercy Hospital Kansas City | |
| ORCHARD- Optimising Home Assessment of Rural Patients | NCT05732922 | Organ Transplan... Cancer Inborn Errors o... Immunosuppressi... COPD Asthma Sickle Cell Dis... | A sphygmanomete... | 18 Years - 100 Years | University of Aberdeen | |
| CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant | NCT02061800 | Chronic Myeloid... Acute Myelogeno... Myelodysplastic... Juvenile Myelom... Acute Lymphobla... Lymphoma (Hodgk... | CliniMACS CD34+... Thiotepa Cyclophosphamid... Alemtuzumab Tacrolimus Melphalan Busulfan Fludarabine Methylprednisol... | - 22 Years | Columbia University | |
| Validating Pain Scales in Children and Young Adults | NCT01639950 | Sickle Cell Dis... Solid Tumor Leukemia Neurofibromatos... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) | NCT05736419 | Sickle Cell Dis... Thalassemia, Be... Thalassemia | Fludarabine Cyclophosphamid... Tacrolimus Mycophenolate M... Rabbit ATG Dexamethasone Bortezomib Rituximab | 2 Years - 50 Years | Memorial Sloan Kettering Cancer Center | |
| COVID-19 Testing in Underserved and Vulnerable Populations | NCT05315908 | Heart Failure Coronary Artery... Cancer Chronic Kidney ... COPD Obesity Sickle Cell Dis... Diabetes Mellit... | Community outre... | 21 Years - | University of California, San Diego | |
| Kid Cards: Teaching Kids About Medicines | NCT00127543 | Hemophilia Sickle Cell Dis... Neoplasms Blood Coagulati... | Medication Educ... | 7 Years - 11 Years | Children's Mercy Hospital Kansas City | |
| Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN) | NCT02895841 | Pain | SMART app weara... | 8 Years - 80 Years | Duke University | |
| ORCHARD- Optimising Home Assessment of Rural Patients | NCT05732922 | Organ Transplan... Cancer Inborn Errors o... Immunosuppressi... COPD Asthma Sickle Cell Dis... | A sphygmanomete... | 18 Years - 100 Years | University of Aberdeen | |
| Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD) | NCT03387033 | Sickle Cell Dis... Virtual Reality Anxiety Depression Cancer | Relaxation resp... | 8 Years - | Duke University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
